{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HepG2 cells", "Leonurus japonicus", "free fatty acids", "high-fat diet", "nonalcoholic fatty liver disease", "obesity"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29295591", "DateCompleted": {"Year": "2018", "Month": "08", "Day": "06"}, "DateRevised": {"Year": "2023", "Month": "09", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "12", "Day": "25"}], "Language": ["eng"], "ELocationID": ["20", "10.3390/nu10010020"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "10", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Dec", "Day": "25"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet.", "Abstract": {"AbstractText": ["We investigated the effects of a <i>Leonurus japonicus</i> ethanol extract (LJE) on nonalcoholic fatty liver disease (NAFLD). An in vitro model of hepatic steatosis was treated with 1 mM free fatty acid (FFA) in HepG2 cells. An in vivo NAFLD model was established using C57BL/6 mice fed a high-fat diet (HFD) and administered LJE (100 or 200 mg/kg) orally for 14 weeks. LJE treatment suppressed lipid accumulation and intracellular triglyceride levels significantly in a concentration-dependent manner in HepG2 cells. Moreover, LJE significantly reduced the expression of sterol regulatory element binding protein 1-c, and its downstream genes, which are associated with lipogenesis, in HepG2 cells. In HFD-fed mice, LJE treatment decreased body weight significantly and decreased serum alanine transaminase levels to normal values, concurrent with a decrease in hepatic lipid accumulation. Furthermore, LJE supplementation ameliorated insulin sensitivity by decreasing serum glucose and insulin levels. LJE improved hepatic steatosis by increasing the expression of phosphorylated AMP-activated protein kinase and peroxisome proliferator-activated receptor-\u03b1 in HFD-fed mice and FFA-treated HepG2 cells. The results suggested that LJE might be a potential therapeutic agent to treat NAFLD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Institute of Oriental Medicine, 70 Cheomdan-Ro, Dong-Gu, Daegu 41062, Korea. withme@kiom.re.kr."}], "LastName": "Lee", "ForeName": "Mi-Ra", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Institute of Oriental Medicine, 70 Cheomdan-Ro, Dong-Gu, Daegu 41062, Korea. kipark@kiom.re.kr."}], "LastName": "Park", "ForeName": "Kwang Il", "Initials": "KI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Institute of Oriental Medicine, 70 Cheomdan-Ro, Dong-Gu, Daegu 41062, Korea. jyma@kiom.re.kr."}], "LastName": "Ma", "ForeName": "Jin Yeul", "Initials": "JY"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Fatty Acids, Nonesterified"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "PPAR alpha"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "SREBF1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Sterol Regulatory Element Binding Protein 1"}, {"RegistryNumber": "0", "NameOfSubstance": "Triglycerides"}, {"RegistryNumber": "EC 2.7.11.31", "NameOfSubstance": "AMP-Activated Protein Kinases"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "AMP-Activated Protein Kinases"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Blood Glucose"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Cytoprotection"}, {"QualifierName": [], "DescriptorName": "Diet, High-Fat"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["toxicity"], "DescriptorName": "Fatty Acids, Nonesterified"}, {"QualifierName": [], "DescriptorName": "Hep G2 Cells"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Hepatocytes"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood"], "DescriptorName": "Insulin"}, {"QualifierName": [], "DescriptorName": "Insulin Resistance"}, {"QualifierName": ["chemistry"], "DescriptorName": "Leonurus"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lipogenesis"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Liver"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["blood", "etiology", "pathology", "prevention & control"], "DescriptorName": "Non-alcoholic Fatty Liver Disease"}, {"QualifierName": ["metabolism"], "DescriptorName": "PPAR alpha"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Sterol Regulatory Element Binding Protein 1"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Triglycerides"}, {"QualifierName": ["drug effects"], "DescriptorName": "Weight Loss"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Farrell G.C., Larter C.Z. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology. 2006;43:S99\u2013S112. doi: 10.1002/hep.20973.", "ArticleIdList": ["10.1002/hep.20973", "16447287"]}, {"Citation": "Parekh S., Anania F.A. Abnormal lipid and glucose metabolism in obesity: Implications for nonalcoholic fatty liver disease. Gastroenterology. 2007;132:2191\u20132207. doi: 10.1053/j.gastro.2007.03.055.", "ArticleIdList": ["10.1053/j.gastro.2007.03.055", "17498512"]}, {"Citation": "Hardy T., Oakley F., Anstee Q.M., Day C.P. Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum. Annu. Rev. Pathol. 2016;11:451\u2013496. doi: 10.1146/annurev-pathol-012615-044224.", "ArticleIdList": ["10.1146/annurev-pathol-012615-044224", "26980160"]}, {"Citation": "Gao M., Ma Y., Liu D. High-fat diet-induced adiposity, adipose inflammation, hepatic steatosis and hyperinsulinemia in outbred CD-1 mice. PLoS ONE. 2015;10:e0119784. doi: 10.1371/journal.pone.0119784.", "ArticleIdList": ["10.1371/journal.pone.0119784", "PMC4358885", "25768847"]}, {"Citation": "Nakamura A., Terauchi Y. Lessons from mouse models of high-fat diet-induced NAFLD. Int. J. Mol. Sci. 2013;14:21240\u201321257. doi: 10.3390/ijms141121240.", "ArticleIdList": ["10.3390/ijms141121240", "PMC3856002", "24284392"]}, {"Citation": "Takahashi Y., Soejima Y., Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J. Gastroenterol. 2012;18:2300\u20132308. doi: 10.3748/wjg.v18.i19.2300.", "ArticleIdList": ["10.3748/wjg.v18.i19.2300", "PMC3353364", "22654421"]}, {"Citation": "Gomez-Lechon M.J., Donato M.T., Martinez-Romero A., Jimenez N., Castell J.V., O\u2019Connor J.E. A human hepatocellular In Vitro model to investigate steatosis. Chem. Biol. Interact. 2007;165:106\u2013116. doi: 10.1016/j.cbi.2006.11.004.", "ArticleIdList": ["10.1016/j.cbi.2006.11.004", "17188672"]}, {"Citation": "Kanuri G., Bergheim I. In Vitro and In Vivo models of non-alcoholic fatty liver disease (NAFLD) Int. J. Mol. Sci. 2013;14:11963\u201311980. doi: 10.3390/ijms140611963.", "ArticleIdList": ["10.3390/ijms140611963", "PMC3709766", "23739675"]}, {"Citation": "Beaton M.D. Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Can. J. Gastroenterol. 2012;26:353\u2013357. doi: 10.1155/2012/725468.", "ArticleIdList": ["10.1155/2012/725468", "PMC3378283", "22720278"]}, {"Citation": "Bahmani M., Eftekhari Z., Saki K., Fazeli-Moghadam E., Jelodari M., Rafieian-Kopaei M. Obesity Phytotherapy: Review of Native Herbs Used in Traditional Medicine for Obesity. J. Evid.-Based Complement. Altern. Med. 2016;21:228\u2013234. doi: 10.1177/2156587215599105.", "ArticleIdList": ["10.1177/2156587215599105", "26269377"]}, {"Citation": "Bahmani M., Mirhoseini M., Shirzad H., Sedighi M., Shahinfard N., Rafieian-Kopaei M. A review on promising natural agents effective on hyperlipidemia. J. Evid.-Based Complement. Altern. Med. 2015;20:228\u2013238. doi: 10.1177/2156587214568457.", "ArticleIdList": ["10.1177/2156587214568457", "25633423"]}, {"Citation": "Wu H., Fronczek F.R., Ferreira D., Burandt C.L., Jr., Zjawiony J.K. Labdane diterpenoids from Leonurus sibiricus. J. Nat. Prod. 2011;74:831\u2013836. doi: 10.1021/np100956k.", "ArticleIdList": ["10.1021/np100956k", "PMC3081930", "21375312"]}, {"Citation": "Shang X., Pan H., Wang X., He H., Li M. Leonurus japonicus Houtt.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J. Ethnopharmacol. 2014;152:14\u201332. doi: 10.1016/j.jep.2013.12.052.", "ArticleIdList": ["10.1016/j.jep.2013.12.052", "24412548"]}, {"Citation": "Shin H.Y., Kim S.H., Kang S.M., Chang I.J., Kim S.Y., Jeon H., Leem K.H., Park W.H., Lim J.P., Shin T.Y. Anti-inflammatory activity of Motherwort (Leonurus sibiricus L.) Immunopharmacol. Immunotoxicol. 2009;31:209\u2013213. doi: 10.1080/08923970802135443.", "ArticleIdList": ["10.1080/08923970802135443", "19514995"]}, {"Citation": "Liu X., Pan L., Gong Q., Zhu Y. Leonurine (SCM-198) improves cardiac recovery in rat during chronic infarction. Eur. J. Pharmacol. 2010;649:236\u2013241. doi: 10.1016/j.ejphar.2010.08.056.", "ArticleIdList": ["10.1016/j.ejphar.2010.08.056", "20854808"]}, {"Citation": "Kim J., Kim M.H., Choi Y.Y., Hong J., Yang W.M. Inhibitory effects of Leonurus sibiricus on weight gain after menopause in ovariectomized and high-fat diet-fed mice. J. Nat. Med. 2016;70:522\u2013530. doi: 10.1007/s11418-016-0971-7.", "ArticleIdList": ["10.1007/s11418-016-0971-7", "26899238"]}, {"Citation": "Lee J.H., Lee J.J., Cho W.K., Yim N.H., Kim H.K., Yun B., Ma J.Y. KBH-1, an herbal composition, improves hepatic steatosis and leptin resistance in high-fat diet-induced obese rats. BMC Complement. Altern. Med. 2016;16:355. doi: 10.1186/s12906-016-1265-z.", "ArticleIdList": ["10.1186/s12906-016-1265-z", "PMC5020448", "27618865"]}, {"Citation": "Toye A.A., Dumas M.E., Blancher C., Rothwell A.R., Fearnside J.F., Wilder S.P., Bihoreau M.T., Cloarec O., Azzouzi I., Young S., et al. Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia. 2007;50:1867\u20131879. doi: 10.1007/s00125-007-0738-5.", "ArticleIdList": ["10.1007/s00125-007-0738-5", "17618414"]}, {"Citation": "Misra A., Bhardwaj S. International Nutrition: Achieving Millennium Goals and Beyond. Volume 78. Karger Publishers; Basel, Switzerland: 2014. Obesity and the metabolic syndrome in developing countries: Focus on South Asians; pp. 133\u2013140.", "ArticleIdList": ["24504214"]}, {"Citation": "Zhang Y., Deng S., Qu L., An Y.T., Wu C.H., Han L.F., Gao X.M., Wang T. Rare syringyl acylated flavonol glycosides from the aerial parts of Leonurus japonicus Houtt. Molecules. 2013;18:2967\u20132977. doi: 10.3390/molecules18032967.", "ArticleIdList": ["10.3390/molecules18032967", "PMC6270216", "23459305"]}, {"Citation": "Cui B., Liu S., Lin X., Wang J., Li S., Wang Q., Li S. Effects of Lycium barbarum aqueous and ethanol extracts on high-fat-diet induced oxidative stress in rat liver tissue. Molecules. 2011;16:9116\u20139128. doi: 10.3390/molecules16119116.", "ArticleIdList": ["10.3390/molecules16119116", "PMC6264384", "22045040"]}, {"Citation": "Yu A.S., Keeffe E.B. Elevated AST or ALT to nonalcoholic fatty liver disease: Accurate predictor of disease prevalence? Am. J. Gastroenterol. 2003;98:955\u2013956. doi: 10.1111/j.1572-0241.2003.07485.x.", "ArticleIdList": ["10.1111/j.1572-0241.2003.07485.x", "12809814"]}, {"Citation": "Day C.P., James O.F. Steatohepatitis: A tale of two \u201chits\u201d? Gastroenterology. 1998;114:842\u2013845. doi: 10.1016/S0016-5085(98)70599-2.", "ArticleIdList": ["10.1016/S0016-5085(98)70599-2", "9547102"]}, {"Citation": "Schmidt S., Jakab M., Jav S., Streif D., Pitschmann A., Zehl M., Purevsuren S., Glasl S., Ritter M. Extracts from Leonurus sibiricus L. increase insulin secretion and proliferation of rat INS-1E insulinoma cells. J. Ethnopharmacol. 2013;150:85\u201394. doi: 10.1016/j.jep.2013.08.013.", "ArticleIdList": ["10.1016/j.jep.2013.08.013", "23978659"]}, {"Citation": "Fabbrini E., Sullivan S., Klein S. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679\u2013689. doi: 10.1002/hep.23280.", "ArticleIdList": ["10.1002/hep.23280", "PMC3575093", "20041406"]}, {"Citation": "Kawano Y., Cohen D.E. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J. Gastroenterol. 2013;48:434\u2013441. doi: 10.1007/s00535-013-0758-5.", "ArticleIdList": ["10.1007/s00535-013-0758-5", "PMC3633701", "23397118"]}, {"Citation": "Reddy J.K., Rao M.S. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am. J. Physiol. Gastrointest. Liver Physiol. 2006;290:G852\u2013G858. doi: 10.1152/ajpgi.00521.2005.", "ArticleIdList": ["10.1152/ajpgi.00521.2005", "16603729"]}, {"Citation": "Horton J.D., Goldstein J.L., Brown M.S. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Investig. 2002;109:1125\u20131131. doi: 10.1172/JCI0215593.", "ArticleIdList": ["10.1172/JCI0215593", "PMC150968", "11994399"]}, {"Citation": "Ahmed M.H., Byrne C.D. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD) Drug Discov. Today. 2007;12:740\u2013747. doi: 10.1016/j.drudis.2007.07.009.", "ArticleIdList": ["10.1016/j.drudis.2007.07.009", "17826687"]}, {"Citation": "Ota T., Takamura T., Kurita S., Matsuzawa N., Kita Y., Uno M., Akahori H., Misu H., Sakurai M., Zen Y., et al. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology. 2007;132:282\u2013293. doi: 10.1053/j.gastro.2006.10.014.", "ArticleIdList": ["10.1053/j.gastro.2006.10.014", "17241878"]}, {"Citation": "Koonen D.P., Jacobs R.L., Febbraio M., Young M.E., Soltys C.L., Ong H., Vance D.E., Dyck J.R. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes. 2007;56:2863\u20132871. doi: 10.2337/db07-0907.", "ArticleIdList": ["10.2337/db07-0907", "17728375"]}, {"Citation": "Mao J., DeMayo F.J., Li H., Abu-Elheiga L., Gu Z., Shaikenov T.E., Kordari P., Chirala S.S., Heird W.C., Wakil S.J. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc. Natl. Acad. Sci. USA. 2006;103:8552\u20138557. doi: 10.1073/pnas.0603115103.", "ArticleIdList": ["10.1073/pnas.0603115103", "PMC1570106", "16717184"]}, {"Citation": "Henin N., Vincent M.F., Gruber H.E., Van den Berghe G. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J. 1995;9:541\u2013546.", "ArticleIdList": ["7737463"]}, {"Citation": "Ruderman N.B., Carling D., Prentki M., Cacicedo J.M. AMPK, insulin resistance, and the metabolic syndrome. J. Clin. Investig. 2013;123:2764\u20132772. doi: 10.1172/JCI67227.", "ArticleIdList": ["10.1172/JCI67227", "PMC3696539", "23863634"]}, {"Citation": "Kang H.S., Cho H.C., Lee J.H., Oh G.T., Koo S.H., Park B.H., Lee I.K., Choi H.S., Song D.K., Im S.S. Metformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states. Sci. Rep. 2016;6:23665. doi: 10.1038/srep23665.", "ArticleIdList": ["10.1038/srep23665", "PMC4806307", "27009398"]}, {"Citation": "Bruce C.R., Hoy A.J., Turner N., Watt M.J., Allen T.L., Carpenter K., Cooney G.J., Febbraio M.A., Kraegen E.W. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes. 2009;58:550\u2013558. doi: 10.2337/db08-1078.", "ArticleIdList": ["10.2337/db08-1078", "PMC2646053", "19073774"]}, {"Citation": "Musso G., Gambino R., Cassader M. Emerging molecular targets for the treatment of nonalcoholic fatty liver disease. Annu. Rev. Med. 2010;61:375\u2013392. doi: 10.1146/annurev.med.60.101107.134820.", "ArticleIdList": ["10.1146/annurev.med.60.101107.134820", "20059344"]}]}], "History": [{"Year": "2017", "Month": "11", "Day": "3"}, {"Year": "2017", "Month": "12", "Day": "15"}, {"Year": "2017", "Month": "12", "Day": "22"}, {"Year": "2018", "Month": "1", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["29295591", "PMC5793248", "10.3390/nu10010020", "nu10010020"]}}]}